Trillium Therapeutics USA Inc is a biopharmaceutical company based in Cambridge, MA, specializing in the development of innovative therapies for cancer treatment. Their research focuses on advancing novel approaches to target and eliminate cancer cells.
With a dedicated team of scientists and researchers, Trillium Therapeutics USA Inc is committed to pushing the boundaries of cancer therapy and making a positive impact on patients' lives. Their cutting-edge technology and strategic partnerships drive their mission to bring new treatment options to those affected by cancer.
Generated from their business information